Sònia Pernas
Biomedical Research Networking Center on Neurodegenerative Diseases(ES)Institut d'Investigació Biomédica de Bellvitge(ES)Institut Català d'Oncologia(ES)Institute for Research in Biomedicine(ES)Duran i Reynals Hospital(ES)Spanish Ovarian Cancer Research Group(ES)Consorci Institut D'Investigacions Biomediques August Pi I Sunyer(ES)Universitat de Barcelona(ES)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, Cancer Genomics and Diagnostics
Most-Cited Works
- → HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance(2019)348 cited
- → HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial(2017)336 cited
- → CDK4/6 inhibition in breast cancer: current practice and future directions(2018)311 cited
- → Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer(2019)277 cited
- → Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer(2020)183 cited
- → HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis